Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Johnson & Johnson (DE:JNJ)
XETRA:JNJ
Johnson & Johnson (JNJ) Stock Price & Analysis
129 Followers
JNJ Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€132.44 - €156.30
Previous Close€138.04
Volume522.00
Average Volume (3M)3.40K
Market Cap
€333.36B
Enterprise Value€340.17B
Total Cash (Recent Filing)$26.22B
Total Debt (Recent Filing)$33.63B
Price to Earnings (P/E)21.6
Beta0.02
Next Earnings
Oct 15, 2024EPS Estimate
€2.21Last Dividend Ex-Date
May 20, 2024Dividend Yield3.22%
Share Statistics
EPS (TTM)6.40
Shares Outstanding2,406,679,183
10 Day Avg. Volume2,875
30 Day Avg. Volume3,403
Standard Deviation0.05
R-Squared0.09
Alpha0.00456
Financial Highlights & Ratios
Price to Book (P/B)-405.89
Price to Sales (P/S)3.92
Price to Cash Flow (P/CF)24.50
P/FCF Ratio30.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.79
Enterprise Value/Gross Profit5.80
Enterprise Value/Ebitda27.20
Forecast
1Y Price Target
€160.29Price Target Upside12.77% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
Johnson & Johnson News
Bulls Say, Bears Say
Bulls Say
MedTech Business ImprovementDynamics across the MedTech business suggest a continued gradual improvement in the business as led by the cardiology verticals.
Productivity And Pipeline ResultsThe company has been productive in delivering positive results from key pipeline readouts from across the portfolio.
Sales GuidanceThe company is expected to raise its 2024 sales guidance.
Bears Say
LitigationOngoing Talc litigation could be more costly than expected and poses a significant risk to the company's outlook.
Product CompetitionThe imminent entry of Stelara biosimilars in Europe marks the start of a key headwind to growth and constrain margin expansion potential.
Product RecallJNJ recently recalled its Varipulse PFA catheter in Europe and Japan due to the product not meeting specifications, which may have led to a couple of strokes.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.20% Insiders
18.58% Mutual Funds
21.77% Other Institutional Investors
59.45% Public Companies and
Individual Investors
JNJ FAQ
What was Johnson & Johnson’s price range in the past 12 months?
Johnson & Johnson lowest stock price was €132.44 and its highest was €156.30 in the past 12 months.
What is Johnson & Johnson’s market cap?
Currently, no data Available
When is Johnson & Johnson’s upcoming earnings report date?
Johnson & Johnson’s upcoming earnings report date is Oct 15, 2024 which is in 89 days.
How were Johnson & Johnson’s earnings last quarter?
Johnson & Johnson released its earnings results on Jul 17, 2024. The company reported €2.587 earnings per share for the quarter, beating the consensus estimate of €2.487 by €0.1.
Is Johnson & Johnson overvalued?
According to Wall Street analysts Johnson & Johnson’s price is currently Undervalued.
Does Johnson & Johnson pay dividends?
Johnson & Johnson pays a Quarterly dividend of €1.14 which represents an annual dividend yield of 3.22%. See more information on Johnson & Johnson dividends here
What is Johnson & Johnson’s EPS estimate?
Johnson & Johnson’s EPS estimate is €2.21.
How many shares outstanding does Johnson & Johnson have?
Johnson & Johnson has 2,406,679,200 shares outstanding.
What happened to Johnson & Johnson’s price movement after its last earnings report?
Johnson & Johnson reported an EPS of €2.587 in its last earnings report, beating expectations of €2.487. Following the earnings report the stock price went up 3.347%.
Which hedge fund is a major shareholder of Johnson & Johnson?
Among the largest hedge funds holding Johnson & Johnson’s share is Fisher Asset Management LLC. It holds Johnson & Johnson’s shares valued at 1B.
---
Johnson & Johnson Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€160.29 (12.77% Upside)
€160.29 (12.77% Upside)
Blogger Sentiment
Bullish
DE:JNJ Sentiment 88%
Sector Average 72%
Sector Average 72%
News Sentiment
Very Bullish
Bullish news 80%
Bearish news 20%
Bearish news 20%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-2.58%
12-Months-Change
Fundamentals
Return on Equity
23.91%
Trailing 12-Months
Asset Growth
-12.25%
Trailing 12-Months
Company Description
Johnson & Johnson
Johnson & Johnson provides healthcare products across three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
---
JNJ Company Deck
---
JNJ Earnings Call
Q2 2024
0:00 / 0:00
---
JNJ Sales Breakdown
64.30% Innovative Medicine
35.70% MedTech
---
JNJ Stock 12 Month Forecast
Average Price Target
€160.29
▲(12.77% Upside)
Technical Analysis
Johnson & Johnson
―
Pfizer
―
Merck & Company
―
Abbott Laboratories
―
Bristol-Myers Squibb
―
Best Analysts Covering JNJ
1 Year
1 Year Success Rate
21/23 ratings generated profit
1 Year Average Return
+9.02%
reiterated a buy rating 2 months ago
Copying Danielle Antalffy's trades and holding each position for 1 Year would result in 91.30% of your transactions generating a profit, with an average return of +9.02% per trade.
---